pirarubicin and bisantrene

pirarubicin has been researched along with bisantrene* in 1 studies

Other Studies

1 other study(ies) available for pirarubicin and bisantrene

Article	Year
Sensitivity of human pancreatic carcinoma cell line (MIA PaCa-2) to Bisantrene and Theprubicin in vitro. In vitro, 1984, Volume: 20, Issue:9 We tested the effect of Bisantrene (BS) and Theprubicin (THP-ADR) on cell growth of a human pancreatic carcinoma cell line (MIA PaCa-2). After 1 h exposure ID50 of BS or THP-ADR was 3 X 10(-7) and 5 X 10(-8) M, respectively. Increasing the exposure time from 1 h to continuous exposure for 5d resulted in 11-fold decrease in ID50 for BS and a 6-fold decrease for THP-ADR. Both drugs inhibited [14C]thymidine incorporation to the same extent and caused an accumulation of cells into G2 + M phase of the cell cycle. Topics: Anthracenes; Antibiotics, Antineoplastic; Cell Division; Cell Line; DNA; Doxorubicin; Humans; Pancreatic Neoplasms	1984

Article

Year

Sensitivity of human pancreatic carcinoma cell line (MIA PaCa-2) to Bisantrene and Theprubicin in vitro.

In vitro, 1984, Volume: 20, Issue:9

We tested the effect of Bisantrene (BS) and Theprubicin (THP-ADR) on cell growth of a human pancreatic carcinoma cell line (MIA PaCa-2). After 1 h exposure ID50 of BS or THP-ADR was 3 X 10(-7) and 5 X 10(-8) M, respectively. Increasing the exposure time from 1 h to continuous exposure for 5d resulted in 11-fold decrease in ID50 for BS and a 6-fold decrease for THP-ADR. Both drugs inhibited [14C]thymidine incorporation to the same extent and caused an accumulation of cells into G2 + M phase of the cell cycle.

Topics: Anthracenes; Antibiotics, Antineoplastic; Cell Division; Cell Line; DNA; Doxorubicin; Humans; Pancreatic Neoplasms

1984